# The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial.

> **NCT06633068** · PHASE2 · RECRUITING · sponsor: **Cairo University** · enrollment: 54 (estimated)

## Conditions studied

- Intra and Postoperative Pain Management

## Interventions

- **DRUG:** Adding perineural Nalbuphine to Bupivacaine in superficial cervical nerve block

## Key facts

- **NCT ID:** NCT06633068
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2025-04
- **Final completion:** 2025-07
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06633068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06633068, "The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06633068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*